This report from Roots Analysis provides an overview of the deep learning domain in the healthcare industry, with a focus on drug discovery and diagnostics. It provides an analysis of the current market landscape, which is dominated by small players, and highlights the presence of over 70 players offering deep learning-powered services and technologies for drug discovery, and over 130 players offering deep learning technologies for diagnostic applications. Additionally, the report also highlights the emergence of over 35 start-ups focused on deep learning in diagnostics in the last 8 years.
